Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment

BACKGROUND: High morbidity and mortality rates of the COVID-19 pandemic have made it a global health priority. Acute respiratory distress syndrome (ARDS) is one of the most important causes of death in COVID-19 patients. Mesenchymal stem cells have been the subject of many clinical trials for the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghayan, Hamid Reza, Salimian, Fatemeh, Abedini, Atefeh, Fattah Ghazi, Samrand, Yunesian, Masud, Alavi-Moghadam, Sepideh, Makarem, Jalil, Majidzadeh-A, Keivan, Hatamkhani, Ali, Moghri, Maryam, Danesh, Abbas, Haddad-Marandi, Mohammad Reza, Sanati, Hassan, Abbasvandi, Fereshteh, Arjmand, Babak, Azimi, Pourya, Ghavamzadeh, Ardeshir, Sarrami-Forooshani, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330663/
https://www.ncbi.nlm.nih.gov/pubmed/35902979
http://dx.doi.org/10.1186/s13287-022-02953-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330663/
https://www.ncbi.nlm.nih.gov/pubmed/35902979
http://dx.doi.org/10.1186/s13287-022-02953-6

Ejemplares similares